Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Structure- and Interaction-Based Design of Anti-SARS-CoV-2 Aptamers.
Mironov V, Shchugoreva IA, Artyushenko PV, Morozov D, Borbone N, Oliviero G, Zamay TN, Moryachkov RV, Kolovskaya OS, Lukyanenko KA, Song Y, Merkuleva IA, Zabluda VN, Peters G, Koroleva LS, Veprintsev DV, Glazyrin YE, Volosnikova EA, Belenkaya SV, Esina TI, Isaeva AA, Nesmeyanova VS, Shanshin DV, Berlina AN, Komova NS, Svetlichnyi VA, Silnikov VN, Shcherbakov DN, Zamay GS, Zamay SS, Smolyarova T, Tikhonova EP, Chen KH, Jeng US, Condorelli G, de Franciscis V, Groenhof G, Yang C, Moskovsky AA, Fedorov DG, Tomilin FN, Tan W, Alexeev Y, Berezovski MV, Kichkailo AS. Mironov V, et al. Among authors: nesmeyanova vs. Chemistry. 2022 Feb 24;28(12):e202104481. doi: 10.1002/chem.202104481. Epub 2022 Feb 9. Chemistry. 2022. PMID: 35025110 Free PMC article.
Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems.
Merkuleva IA, Shcherbakov DN, Borgoyakova MB, Shanshin DV, Rudometov AP, Karpenko LI, Belenkaya SV, Isaeva AA, Nesmeyanova VS, Kazachinskaia EI, Volosnikova EA, Esina TI, Zaykovskaya AV, Pyankov OV, Borisevich SS, Shelemba AA, Chikaev AN, Ilyichev AA. Merkuleva IA, et al. Among authors: nesmeyanova vs. Vaccines (Basel). 2022 Jan 9;10(1):96. doi: 10.3390/vaccines10010096. Vaccines (Basel). 2022. PMID: 35062757 Free PMC article.
Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice.
Borgoyakova MB, Karpenko LI, Rudometov AP, Volosnikova EA, Merkuleva IA, Starostina EV, Zadorozhny AM, Isaeva AA, Nesmeyanova VS, Shanshin DV, Baranov KO, Volkova NV, Zaitsev BN, Orlova LA, Zaykovskaya AV, Pyankov OV, Danilenko ED, Bazhan SI, Shcherbakov DN, Taranin AV, Ilyichev AA. Borgoyakova MB, et al. Among authors: nesmeyanova vs. Int J Mol Sci. 2022 Feb 16;23(4):2188. doi: 10.3390/ijms23042188. Int J Mol Sci. 2022. PMID: 35216301 Free PMC article.
Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
Merkuleva IA, Shcherbakov DN, Borgoyakova MB, Isaeva AA, Nesmeyanova VS, Volkova NV, Aripov VS, Shanshin DV, Karpenko LI, Belenkaya SV, Kazachinskaia EI, Volosnikova EA, Esina TI, Sergeev AA, Titova KA, Konyakhina YV, Zaykovskaya AV, Pyankov OV, Kolosova EA, Viktorina OE, Shelemba AA, Rudometov AP, Ilyichev AA. Merkuleva IA, et al. Among authors: nesmeyanova vs. Viruses. 2022 May 16;14(5):1060. doi: 10.3390/v14051060. Viruses. 2022. PMID: 35632800 Free PMC article.
[Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein].
Borgoyakova MB, Karpenko LI, Rudometov AP, Shanshin DV, Isaeva AA, Nesmeyanova VS, Volkova NV, Belenkaya SV, Murashkin DE, Shcherbakov DN, Volosnikova EA, Starostina EV, Orlova LA, Danilchenko NV, Zaikovskaya AV, Pyankov OV, Ilyichev AA. Borgoyakova MB, et al. Among authors: nesmeyanova vs. Mol Biol (Mosk). 2021 Nov-Dec;55(6):987-998. doi: 10.31857/S0026898421060045. Mol Biol (Mosk). 2021. PMID: 34837703 Free article. Russian.
Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein.
Borgoyakova MB, Karpenko LI, Rudometov AP, Shanshin DV, Isaeva AA, Nesmeyanova VS, Volkova NV, Belenkaya SV, Murashkin DE, Shcherbakov DN, Volosnikova EA, Starostina EV, Orlova LA, Danilchenko NV, Zaikovskaya AV, Pyankov OV, Ilyichev AA. Borgoyakova MB, et al. Among authors: nesmeyanova vs. Mol Biol. 2021;55(6):889-898. doi: 10.1134/S0026893321050046. Epub 2021 Dec 17. Mol Biol. 2021. PMID: 34955558 Free PMC article.
The Search for Single-Domain Antibodies Interacting with the Receptor-Binding Domain of SARS-CoV-2 Surface Protein.
Aripov VS, Volkova NV, Taranin AV, Mechetina LV, Chikaev NA, Nayakshin AM, Nesmeyanova VS, Isaeva AA, Merkul'eva YA, Shanshin DV, Belenkaya SV, Ilyichev AA, Shcherbakov DN. Aripov VS, et al. Among authors: nesmeyanova vs. Bull Exp Biol Med. 2023 Jun;175(2):225-228. doi: 10.1007/s10517-023-05839-6. Epub 2023 Jul 19. Bull Exp Biol Med. 2023. PMID: 37464199
SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice.
Volosnikova EA, Merkuleva IA, Esina TI, Shcherbakov DN, Borgoyakova MB, Isaeva AA, Nesmeyanova VS, Volkova NV, Belenkaya SV, Zaykovskaya AV, Pyankov OV, Starostina EV, Zadorozhny AM, Zaitsev BN, Karpenko LI, Ilyichev AA, Danilenko ED. Volosnikova EA, et al. Among authors: nesmeyanova vs. Vaccines (Basel). 2023 Apr 6;11(4):808. doi: 10.3390/vaccines11040808. Vaccines (Basel). 2023. PMID: 37112720 Free PMC article.
Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19.
Borgoyakova MB, Karpenko LI, Merkulyeva IA, Shcherbakov DN, Rudometov AP, Starostina EV, Shanshin DV, Isaeva AA, Nesmeyanova VS, Volkova NV, Belenkaya SV, Volosnikova EA, Zadorozhny AM, Orlova LA, Zaykovskaya AV, Pyankov OV, Bazhan SI, Ilyichev AA. Borgoyakova MB, et al. Among authors: nesmeyanova vs. Bull Exp Biol Med. 2022 Dec;174(2):246-249. doi: 10.1007/s10517-023-05682-9. Epub 2023 Jan 4. Bull Exp Biol Med. 2022. PMID: 36598669 Free PMC article.
11 results